SAO PAULO, Oct. 31, 2013 /PRNewswire/ -- Companhia de
Bebidas das Americas – Ambev [BOVESPA: AMBV4, AMBV3; NYSE: ABV,
ABVc] announces today the results for the 2013 third quarter. The
following operating and financial information, unless otherwise
indicated, is presented in nominal Reais and prepared
according to International Financial Reporting Standards (IFRS),
and should be read together with our quarterly financial
information for the three and nine months period ended September 30, 2013 filed with the CVM and
submitted to the SEC.
Operating and Financial Highlights
Top line performance: Our net revenues increased 4.0%,
with a volume decline of 3.1% being more than offset by 7.3% growth
in net revenue per hectoliter (NR/Hl). Accordingly, though
industry softness in Brazil,
Canada, and, to a lesser extent,
Argentina, continued to impact
volume performance, this was another quarter of top line growth in
nearly all our divisions (Brazil Beer +0.8%, Brazil CSD & NANC
+5.4%, HILA-ex +10.7%, LAS +14.8%, while Canada -0.1%) thanks to solid NR/Hl
performance (Brazil Beer +6.0%, Brazil CSD & NANC +7.6%,
HILA-ex +10.9%, LAS +15.1% and Canada +2.2%).
Cost of Goods Sold (COGS): COGS grew at 5.8%, with
COGS/Hl increasing 9.3%. Such performance represents an
improvement over our H1 2013 results (COGS +9.0%; COGS/Hl +13.9%),
and came mostly from our Brazilian business, where commodity hedges
(primarily barley and aluminum) helped to soften pressure coming
from currency hedges, higher industrial depreciation linked to
capital expenditures, as well as packaging mix in Brazil Beer.
Selling, General & Administrative (SG&A)
expenses: SG&A expenses (excluding depreciation and
amortization) improved significantly and were down 0.5%. Such
improvement is explained by commercial spend growing at a lower
pace than H1 2013 (without compromising investments behind our
brands and innovation) and by the savings generated from our cost
management initiatives around "non-working money", also helped by
lower provisions related to variable compensation.
Distribution expenses were higher due mainly to the greater weight
of direct distribution in Brazil
and inflationary pressures in Argentina.
EBITDA, Gross margin and EBITDA margin: Our Normalized
EBITDA grew 9.4% and corresponded to R$
4,199.3 million, which also represents an important
improvement if compared to the YoY growth we delivered in the first
half of the year (+4.4%). Gross margin performance improved
in Q3 2013 (ie, -60 basis points vs. -120 bps in H1 2013) driven by
less contraction in Brazil and
expansion in our international divisions, while we delivered strong
EBITDA margin expansion of 250 bps on the back of expansion across
our business units.
Financial
Highlights – Ambev
|
3Q12
|
|
%
As
|
%
|
YTD12
|
|
%
As
|
%
|
Consolidated
|
Reference
|
Reference
|
R$
million
|
Base
|
3Q13
|
Reported
|
Organic
|
Base
|
YTD13
|
Reported
|
Organic
|
Total
volumes
|
40,530.2
|
39,266.2
|
-3.1%
|
-3.1%
|
120,139.1
|
116,180.6
|
-3.3%
|
-3.9%
|
Beer
|
29,371.7
|
28,202.6
|
-4.0%
|
-4.0%
|
86,487.8
|
83,543.5
|
-3.4%
|
-4.2%
|
CSD and
NANC
|
11,158.4
|
11,063.6
|
-0.8%
|
-0.8%
|
33,651.3
|
32,637.1
|
-3.0%
|
-3.2%
|
|
|
|
|
|
|
|
|
|
Net sales
|
8,036.0
|
8,462.6
|
5.3%
|
4.0%
|
22,097.1
|
23,738.5
|
7.4%
|
4.8%
|
Gross
profit
|
5,414.6
|
5,646.4
|
4.3%
|
3.1%
|
14,863.3
|
15,707.2
|
5.7%
|
3.2%
|
Gross
margin
|
67.4%
|
66.7%
|
-70 bps
|
-60 bps
|
67.3%
|
66.2%
|
-110 bps
|
-100 bps
|
EBITDA
|
3,777.8
|
4,192.4
|
11.0%
|
9.5%
|
10,088.0
|
11,003.0
|
9.1%
|
6.5%
|
EBITDA
margin
|
47.0%
|
49.5%
|
250 bps
|
250 bps
|
45.7%
|
46.4%
|
70
bps
|
70
bps
|
Normalized
EBITDA
|
3,787.4
|
4,199.3
|
10.9%
|
9.4%
|
10,124.4
|
11,016.2
|
8.8%
|
6.2%
|
Normalized EBITDA
margin
|
47.1%
|
49.6%
|
250 bps
|
250 bps
|
45.8%
|
46.4%
|
60 bps
|
70
bps
|
Profit - Ambev
holders
|
2,476.9
|
2,280.3
|
-7.9%
|
|
6,695.0
|
6,506.2
|
-2.8%
|
|
Normalized Profit
- Ambev holders
|
2,486.5
|
2,287.2
|
-8.0%
|
|
6,731.4
|
6,519.4
|
-3.1%
|
|
No. of share
outstanding (millions)
|
3,126.2
|
3,132.3
|
|
|
3,126.2
|
3,132.3
|
|
|
EPS
(R$/shares)
|
0.79
|
0.73
|
-8.1%
|
|
2.14
|
2.08
|
-3.0%
|
|
Normalized
EPS
|
0.80
|
0.73
|
-8.2%
|
|
2.15
|
2.08
|
-3.3%
|
|
Note: Earnings per share calculation is based on outstanding
shares (total existing shares excluding shares held in
treasury).
Operating Cash generation and Profit: Cash generated from
our operations improved 7.4%, totalling R$
4,689.8 million. Our Normalized Profit was
R$ 2,287.2 million, declining 8.0%
mostly impacted by higher net finance expenses and a greater
effective tax rate. Normalized Earnings Per Share (EPS)
corresponded to R$ 0.73 (-8.2% vs. Q3
2012).
CAPEX, Pay-out and Financial discipline: We invested
approximately R$ 1 billion during the
quarter in capex (R$ 2.3 billion thru
September 30), of which R$ 847 million were carried out in Brazil.
In terms of pay-out, on September 27
we paid out approximately R$ 2
billion in dividends, bringing our pay-out this year to
R$ 7.1 billion in dividends and IOC
(vs. R$ 3.8 billion during the same
period in 2012), and we also reduced our net cash position to
R$ 2,399.7 million since December 31, 2012.
This press release segregates the impact of organic changes
from those arising from changes in scope or currency translation.
Scope changes represent the impact of acquisitions and
divestitures, the start up or termination of activities or the
transfer of activities between segments, curtailment gains and
losses and year over year changes in accounting estimates and other
assumptions that management does not consider as part of the
underlying performance of the business. Unless stated,
percentage changes in this press release are both organic
and normalized in nature. Whenever used in this document, the term
"normalized" refers to performance measures (EBITDA, EBIT, Profit,
EPS) before special items adjustments. Special items are either
income or expenses which do not occur regularly as part of the
normal activities of the Company. They are presented separately
because they are important for the understanding of the underlying
sustainable performance of the Company due to their size or nature.
Normalized measures are additional measures used by management and
should not replace the measures determined in accordance with IFRS
as indicators of the Company's performance. Comparisons, unless
otherwise stated, refer to the third quarter of 2012 (Q3 2012).
Values in this release may not add up due to rounding.
SOURCE Ambev